Intra-Cellular Therapies Inc. buy Piper Sandler
Start price
15:01
/
50%
€67.00
Target price
06.09.25
€82.70
Performance (%)
1.49%
Price
15:37
€68.00
Summary
This prediction is currently active. With a performance of 1.49%, the BUY prediction by Piper_Sandler for Intra-Cellular Therapies Inc. is trending in the right direction. This prediction currently runs until 06.09.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intra-Cellular Therapies Inc. | 1.49% |
| iShares Core DAX® | -1.414% |
| iShares Nasdaq 100 | -2.316% |
| iShares Nikkei 225® | -2.756% |
| iShares S&P 500 | -1.849% |
Comments by Piper_Sandler for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $92.00 price target on the stock, up previously from $68.00.
Ratings data for ITCI provided by MarketBeat